JIS University

Yes, JIS University allow candidates to pay partial payment for admission confirmation after selection. The remaining amount has to be paid by the deadline mentioned in the selection letter. JIS University DPharm tuition fee (total) is INR 1.7 lakh. The total fee may include other components as well. Moreover, the mentioned fee is as per the official website/sanctioning body. It is still subject to changes and hence, is indicative.

For selection to DPharm course, candidates must have a valid JET score and also fulfil the course-specific eligibility requirements. Aspirants who are Class 12 or equivalent exam pass from a recognised board with a minimum of 50% aggregate can apply. In addition, Physics and Chemistry should have been studied as compulsory subjects, and Biology or Mathematics as the third subject. Candidates must also hold the relevant documents as a proof of eligibility. These documents have to be submitted during form filling and admission.

Yes, JIS University offers four-year BPharm programme. It is offered in a full-time mode. Apart from this, the university also offers BPharm (lateral) course. For the course admission, candidates need to have a valid score of JIS University Entrance Test (JET)/WBJEE. Before applying for admission, the candidates must check out the prescribed eligibility requirements. 

The JIS Unniversity BPharm graduates can pursue postgraduate level courses in the field of pharmacy. Candidates can look out for courses in India or abroad. Before applying for any course admission, aspirants must check the eligibility and selection requirements. The PG courses that the BPharm degree holders can pursue are:MBA in lang="EN-GB">MBA in Pharmaceutical AdministrationPG Diploma in PharmacyDoctor of Pharmacy (DPharma)

The course curriculum include practical subjects to ensure students get hands-on knowledge of the subject. It helps in understanding and makes students industry ready. Some of the practical subjects included in the JIS University BPharm course curriculum are:Pharmaceutical AnalysisRemedial BiologyBiochemistryComputer Applications in PharmacyPharmaceutical EngineeringPharmacology, etc.

The JIS University BPharm curriculum has semester-wise subject details. It includes both theory and practical subjects. Students also have to submit a project work in the last semester of the programme. The topics covered in the first semester are:Human Anatomy and PhysiologyPharmaceutical AnalysisPharmaceuticsPharmaceutical Inorganic ChemistryCommunication SkillsRemedial Biology/Remedial Mathematics

The JIS University cutoff list is prepared as per the JIS University Entrance Test (JET)/WBJEE exam. In 2023, the closing rank in the last round was 91848 for the general all-India category. Students with a rank better or equal to the cutoff become eligible for admission. The cutoff varies every year as it depends upon factors such as the number of applicants, exam scores, and seat availability.

The university admit candidates based on merit in JIS University Entrance Test (JET) or WBJEE. JET is conducted in the month of Aug/Sep. Candidates must apply for the exam before the prescribed deadline. Moreover, the WBJEE 2025 application form is expected to be out in Dec and the test can be conducted in Apr month of the admission year.

There are a total of 10 seats in JIS University for the BPharm (lateral) course. The seat allotment process for this course is based on JIS University Entrance Test (JET) score. JIS may follow the guidelines of the state or central government for seat reservation. Moreover, it must be noted that the mentioned seat intake is as per the official website/sanctioning body. It is still subject to changes and hence, is indicative.

The university has a total seat intake of 100 for the BPharm programme. Students are admitted to the course based on merit in JET/WBJEE exam and as per sanctioned seat intake. The university may follow reservation policy of the state or central government for the seat allotment process. It must be noted that the mentioned seat count is as per the official website/sanctioning body. However, it is still subject to changes and hence, is indicative.